Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 21 -30 of 97 Show results per page	View Search Criteria \| Help With Results

Last Modified: 7/9/2007


21.		Phase III CHOP vs CHOP plus LEV vs CHOP/LEV/BCG with or without LEV Maintenance for Stage III-IV non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				SWOG-7713/14 SWOG-7714

Last Modified: 1/1/1989


22.		Phase III Randomized Comparison of 5-FU vs 5-FU/LEV vs 5-FU plus Hepatic Irradiation in Patients with Unresectable Hepatic Metastases following Resection of Colorectal Carcinoma (Summary Last Modified 01/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				EST-3282 EST-3282

Last Modified: 5/16/2006


23.		Phase III Adjuvant BCG/INH/LEV Immunotherapy vs CAP-I (CTX/ADR/CACP) for Stage II/III Large Cell and Adenocarcinoma of the Lung

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified								LCSG-772

Last Modified: 5/16/2006


24.		Phase III Adjuvant Radiotherapy with or without Levamisole Immunotherapy vs No Therapy for Stage II/III Epidermoid Carcinoma of the Lung

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified								LCSG-773

Last Modified: 12/14/2005


25.		Phase III Adjuvant Levamisole Immunotherapy with vs without 5-Fluorouracil for Surgically Cured Dukes B/C Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				NCCTG-784852 MAYO-784852, NCCTG-78-48-52


26.		Phase III Comparison of 5-FU vs 5-FU/PALA vs 5-FU/LEV vs 5-FU/MeCCNU/VCR/SZC vs 5-FU/TdR for Unresectable or Metastatic Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				NCCTG-804651 MAYO-804651, NCCTG-80-46-51


27.		Phase III Randomized Comparison of DES/LEV vs DES Alone in Stage C/D Prostatic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								NCI-D82-012-793 ICC-81U4

Last Modified: 2/20/2008


28.		Phase III Pilot Adjuvant Therapy with Levamisole vs Levamisole plus 5-Fluorouracil for Resectable Adenocarcinoma of the Colon

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified				NCI				NCCTG-844652 EST-2284, MAYO-844652, SWOG-8591, INT-0035


29.		Phase III Busulfan (BU) Induction Chemotherapy Followed by BU/Levamisole Maintenance vs BU Alone for Good-Risk CML

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				15 to 65								EORTC-06771


30.		Phase III Postoperative Adjuvant Immunotherapy with Levamisole for Dukes C Resectable Adenocarcinoma of the Colon

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								EORTC-40781

Select All on One Page


					< Previous 1 2 3 4 5 6 Next >

| | | | | | | |

A Service of the National Cancer Institute